Vea Health review

What it is

Vea Health is a direct-to-consumer telehealth platform organised into five lines: Longevity (sermorelin), Anti-Aging & Skin (NAD⁺), Weight Loss (compounded semaglutide and tirzepatide in oral and injection protocols), Sexual Health and Hair Growth, with hormone replacement therapy marked coming soon. It states US-sourced, provider-prescribed treatment across all 50 states, accepts FSA and HSA cards, and runs a members area and its own affiliate program alongside the storefront.

How it works

Asynchronous and account-gated. You create an account, complete an intake and a licensed provider decides whether treatment is appropriate — the site says so on every card, in the same block as the compounded disclaimer: provider approval required, not all patients qualify. That pairing is better practice than most of this board manages, because it puts the two most important caveats in the reader's eye at the moment of interest rather than at the bottom of a legal page. Three things are not disclosed and matter. No compounding pharmacy is named, only a US-based pharmacy in the abstract. No medical director or individual clinician is named. And no LegitScript certification is displayed. The site also markets its peptides and NAD⁺ as "triple-tested" without ever defining the phrase — which lab, which assays, which release criteria — so treat it as positioning rather than as a disclosed testing protocol until they answer that. There is a members area, which raises the obvious question of whether a membership fee sits underneath the therapy price; the public site does not say.

Pricing transparency

There is none to assess, and that is the finding. No dollar figure for sermorelin, NAD⁺, GLP-1 medication or anything else appears on any public page; the pricing sits behind account creation. That has not changed since our record was written more than a year ago, which is worth noting on a site that has otherwise been substantially rebuilt — the peptide repositioning was worth doing, publishing a price apparently was not. We therefore publish no floor on either board, and nothing on the site should be read as a sermorelin or NAD⁺ price. Before you hand over a health history, ask three questions in writing: the monthly cost of the sermorelin or NAD⁺ protocol, whether a membership fee is charged on top, and whether you are billed before or only after a provider prescribes. FSA and HSA acceptance is stated, which is useful once you know the number.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Vea reproduces the disclosure verbatim beneath every product — compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality — which is precisely the right wording, and it does not soften it into something vaguer the way many competitors do. Compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, the two headline products sit at different tiers. Sermorelin is a GHRH analogue that prompts your own pituitary to release growth hormone rather than supplying it, preserving the feedback loop that exogenous growth hormone overrides — a real, well-characterised mechanism whose long-term human outcome data stays thin beyond short-term IGF-1 movement. Injected NAD⁺ has no controlled human outcome trials at all; the single human intravenous study was a pharmacokinetic pilot finding infused NAD⁺ clears plasma quickly, and the NAD⁺ forms with human trial data are the oral precursors nicotinamide riboside and nicotinamide mononucleotide, which raise a blood level rather than demonstrate an outcome. Individual results vary.

Pros and watch-outs

The evidence behind what Vea Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• NAD injections: how to get them near you or online, and what the evidence really says

  Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.

How Vea Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

• VWVyora Wellness

  NAD⁺ at one flat published monthly price with no membership and no dose-escalation surcharge

  See Vyora Wellness →
• VHVital Harmony Rx

  People who weight a checkable LegitScript ID and a named physician network above published pricing

  See Vital Harmony Rx →
• VOVoxy

  NAD⁺ buyers who want a named 503A pharmacy and a named medical group and will ask for the price directly

  See Voxy →